Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Advances in Rapid Sex-Steroid Action (eBook)

New Challenges and New Chances in Breast and Prostate Cancers
eBook Download: PDF
2011 | 2012
XVIII, 270 Seiten
Springer New York (Verlag)
978-1-4614-1764-4 (ISBN)

Lese- und Medienproben

Advances in Rapid Sex-Steroid Action -
Systemvoraussetzungen
149,79 inkl. MwSt
(CHF 146,30)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Breast and prostate cancers are both hormone-dependent, at least in some stages of their progression. Hormonal manipulation represents an important therapeutic approach. Although most of breast and prostate cancers initially respond to hormone therapy, most tumors reinitiate to growth. Finally, hormone-resistant and metastatic breast and prostate cancers may develop. Thus, the challenge is the dissection of mechanisms by which steroid receptor signaling pathways continue to influence cell growth and invasiveness. Compelling evidence indicates that steroid hormones elicit non-genomic responses in extra-nuclear compartment of target cells. In this cellular location, steroid-coupled receptors rapidly recruit signaling effectors or scaffold proteins and activate multiple pathways leading to proliferation, survival, migration and invasiveness. The immediate challenge is the dissection of key events regulating the steroid response of target tissues to prevent progression and improve treatment of breast and prostate cancers.
Breast and prostate cancers are both hormone-dependent, at least in some stages of their progression. Hormonal manipulation represents an important therapeutic approach. Although most of breast and prostate cancers initially respond to hormone therapy, most tumors reinitiate to growth. Finally, hormone-resistant and metastatic breast and prostate cancers may develop. Thus, the challenge is the dissection of mechanisms by which steroid receptor signaling pathways continue to influence cell growth and invasiveness. Compelling evidence indicates that steroid hormones elicit non-genomic responses in extra-nuclear compartment of target cells. In this cellular location, steroid-coupled receptors rapidly recruit signaling effectors or scaffold proteins and activate multiple pathways leading to proliferation, survival, migration and invasiveness. The immediate challenge is the dissection of key events regulating the steroid response of target tissues to prevent progression and improve treatment of breast and prostate cancers.

Non genomic action of steroid hormones: more questions than answers.- Part I: Breast Cancer.- Progesterone signaling to chromatin in breast cancer cells. two initial cycles of remodeling.- Cooperative interactions between c-Src, estrogen receptors, and receptor tyrosine kinases in breast cancer.- Cross talk between ERa and Src signaling and its relevance to ER status and hormone responsiveness.- Post-translational modifications of ER alpha in rapid estrogens’ action.- Sex-steroid rapid action and its role in invasiveness and metastasis of breast cancer.- Unraveling the role of GPER in breast cancer.- Nongenomic actions of estrogens and xenoestrogens affecting  endocrine cancer cells.- Part II: Prostate Cancer.- Androgen receptor pathway in prostate cancer: old target and new drugs.- Differential functions of stromal and epithelial androgen receptor in prostate cancer before and after castration resistant stage.- Role of androgens and androgen receptor in prostate cancer: genomic and non-genomic actions.- Mechanisms of signal transduction in prostate cancer: the role of PI3-kinase pathway in androgen action.- The IGF-1 axis in prostate cancer: the role of rapid steroid actions.- Part III: New tools for steroid receptor analysis and regulatory networks.- Quantitative visualization of sex steroid receptor functions: AR and ERa.- Micropatterned surfaces as tools for the study of rapid non-genomic actions of steroid receptors. Index.

Erscheint lt. Verlag 15.12.2011
Zusatzinfo XVIII, 270 p.
Verlagsort New York
Sprache englisch
Themenwelt Medizinische Fachgebiete Innere Medizin Endokrinologie
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Studium
ISBN-10 1-4614-1764-3 / 1461417643
ISBN-13 978-1-4614-1764-4 / 9781461417644
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 6,3 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Das Wichtigste für Ärztinnen und Ärzte aller Fachrichtungen

von Ulrich Alfons Müller; Günther Egidi …

eBook Download (2021)
Urban & Fischer Verlag - Fachbücher
CHF 36,10